Completed PHASE4 INTERVENTIONAL 1-arm NCT00407537

Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors (CRUCIAL)

A Cluster Randomized Trial On Cardiovascular Risk Factor Management: Caduet Versus Usual Care In Subjects With Hypertension And Additional Cardiovascular Risk Factors In Clinical Practice

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions Hypercholesterolemia Hypertension

Interventions Amlodipine besylate/atorvastatin calcium single pill combination

Updated 10 times since 2017 Last updated: Jan 26, 2021 Started: Mar 31, 2007 Primary completion: Oct 31, 2009 Completion: Oct 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00407537, this PHASE4 trial focuses on Hypercholesterolemia and Hypertension and remains completed. Sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc., it has been updated 10 times since 2007, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

10 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Dec 2025 — Present [monthly]

Completed PHASE4
Sep 2025 — Dec 2025 [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Feb 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Feb 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abu Dhabi, United Arab Emirates , Al Ain City, United Arab Emirates , Amman, Jordan , Ankara, Turkey (Türkiye) , Bandung, Indonesia , Bangkok, Thailand , Batu Caves, Malaysia , Beirut, Lebanon , Breznički Hum, Croatia , Brno, Czechia and 77 more locations